Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathologic Misclassification of Renal Cell Carcinoma in Adolescents and Young Adults.

Cancers·2026
Same author

Impact of Centres With Different Patient Volume on Diagnostic Process, Therapeutic Strategy and Outcome in Patients With Localised Rhabdomyosarcoma: A Report From the European paediatric Soft tissue sarcoma Study Group (EpSSG).

Pediatric blood & cancer·2026
Same author

Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG).

Journal of pediatric surgery·2026
Same author

Survivorship After Testicular Cancer in Adolescents and Young Adults: What is Causing Death and When?

The Journal of urology·2026
Same author

Corrigendum to 'Radiotherapy and brachytherapy for cervical cancer : Recommendations of the Société française de radiothérapie oncologique' [Cancer Radiother 29 (2025) 104753].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same author

UNICURE-HD: A Multicentric Retrospective Cohort Study of Single-Insertion Image-Guided high-Dose-Rate Brachytherapy for Locally Advanced Cervical Cancer in the Context of Limited Brachytherapy Access in France.

International journal of radiation oncology, biology, physics·2026

Related Experiment Video

Updated: May 5, 2026

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 7, 2011

15.7K

Local Control of Bladder/Prostate Rhabdomyosarcoma: An Expert Consensus Guideline From the International Soft Tissue

Daniel J Indelicato1, Amanda F Buchanan2, Cyrus Chargari3,4

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida, USA.

Pediatric Blood & Cancer
|March 13, 2026
PubMed
Summary

Local treatment for rhabdomyosarcoma of the bladder and prostate requires a multidisciplinary approach. These guidelines offer expert consensus on managing pediatric soft tissue sarcomas, balancing survival with functional outcomes.

Keywords:
genitourinaryguidelineslocal therapyradiationrhabdomyosarcomasurgery

More Related Videos

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.4K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K

Related Experiment Videos

Last Updated: May 5, 2026

An Orthotopic Model of Murine Bladder Cancer
09:07

An Orthotopic Model of Murine Bladder Cancer

Published on: February 7, 2011

15.7K
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.4K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.1K

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Rhabdomyosarcoma of the bladder and prostate presents complex treatment challenges.
  • Multidisciplinary decision-making is crucial, considering patient age, tumor characteristics, and available resources.
  • Limited long-term functional outcome data complicates treatment planning.

Purpose of the Study:

  • To provide international expert consensus guidelines for the local treatment of pediatric bladder and prostate rhabdomyosarcoma.
  • To inform clinical practice and stimulate discussion on treatment strategies.
  • To identify areas for future research in pediatric soft tissue sarcoma.

Main Methods:

  • Development of guidelines through collaboration between major pediatric oncology study groups (Children's Oncology Group, European Pediatric Soft Tissue Sarcoma Study Group, Cooperative Weichteilsarkom Studiengruppe).
  • Incorporation of expert consensus on key treatment decision factors.
  • Review of current surgical and radiotherapy techniques.

Main Results:

  • Established consensus on multidisciplinary decision-making factors for bladder and prostate rhabdomyosarcoma.
  • Highlighted the need for improved long-term bladder and bowel function outcome data.
  • Provided a framework for managing these rare pediatric tumors.

Conclusions:

  • Treatment for bladder and prostate rhabdomyosarcoma necessitates a comprehensive, multidisciplinary strategy.
  • Improved survival rates necessitate a greater focus on functional outcomes and quality of life.
  • These international guidelines aim to standardize and advance the care of pediatric soft tissue sarcomas.